Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 38Breast Neoplasms 20Pancreatic Neoplasms 19Rectal Neoplasms 18Colonic Neoplasms 17Gastrointestinal Neoplasms 16Prostatic Neoplasms 12Esophageal Neoplasms 12Stomach Neoplasms 11Lung Neoplasms 11Colorectal Neoplasms, Hereditary Nonpolyposis 10Endometrial Neoplasms 9Anus Neoplasms 6Uterine Cervical Neoplasms 4Neoplasms 4Motor Activity 4cyclopia sequence 3Sarcoma 3Ovarian Neoplasms 3Liver Neoplasms 3Head and Neck Neoplasms 3Gastrointestinal Stromal Tumors 3Disease 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Appendiceal Neoplasms 3Vulvar Neoplasms 2Vomiting 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2

Interventions

Ursodeoxycholic Acid 1Surveys and Questionnaires 1Standard of Care 1Interviews as Topic 1High-Throughput Nucleotide Sequencing 1Genetic Testing 1Genetic Counseling 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Syndromes, Hereditary × Surveys and Questionnaires × Gastrointestinal × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡